Meta-Analysis of Bailing Capsule Efficacy for Adult Nephrotic Syndrome

A systematic review and meta-analysis of randomized controlled trials evaluating Bailing Capsule for adult primary nephrotic syndrome. The study includes 11 trials involving 920 adult patients, analyzing outcomes like urinary protein excretion and serum creatinine. The analysis was conducted by Muyuan Guo and published on figshare in April 2026.

Use Cases

• Evaluate the efficacy of Bailing Capsule based on reported reductions in 24-hour urinary protein excretion and serum creatinine.
• Assess the safety profile of a fungal medicinal preparation based on the reported incidence of adverse events.
• Analyze immunological effects based on reported changes in CD3+, CD4+ T lymphocytes and the CD4+/CD8+ ratio.
• Compare adjunctive therapy outcomes against conventional therapy alone based on the overall clinical response rate.

Strengths

• Includes 11 randomized controlled trials, providing a structured evidence synthesis.
• Analyzes data from 920 adult patients, offering a quantifiable sample size.
• Examines multiple clinical endpoints, including renal function indicators and immune markers.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The dataset is a PDF summary (76.5 KB), not the raw trial data, limiting direct analysis.

Provenance

Source

figshare

Collection Method

Systematic review and meta-analysis of RCTs from eight major databases.

Time Range

Literature search from database inception to December 20, 2025.

Freshness

Last updated 2026-04-24 05:40:19; freshness should be verified.